EMOR OTC
Healixa Inc
1W: -4.2%
1M: +21.2%
3M: -36.2%
YTD: +283.0%
1Y: +283.0%
3Y: -84.7%
5Y: -91.1%
$0.04
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$879K
+58.9% ▲
Capital Expenditures
$4
+0.0% ▲
Free Cash Flow
-$879K
+58.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$69K
+161.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$15M | -$3M | -$645K | -$7M |
| Depreciation & Amort. | $88K | $86K | $23K | $33K | $33K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $48K | -$374K | $410K | $3K | $146K |
| Other Non-Cash Items | $5K | $14M | $716K | -$2M | $6M |
| Operating Cash Flow | -$965K | -$2M | -$2M | -$2M | -$879K |
| — Investing Activities — | |||||
| Capital Expenditures | -$274K | -$22K | -$115K | $0 | -$4 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$50K | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $4 |
| Investing Cash Flow | -$274K | -$72K | -$115K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $645K | $588K | $2M | $2M | $912K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $361K | $15K | $0 | $0 | -$13K |
| Financing Cash Flow | $1M | $2M | $2M | $2M | $949K |
| Net Change in Cash | $2K | $159K | -$61K | -$112K | $69K |
| Cash End of Period | $37K | $196K | $135K | $23K | $92K |
| Free Cash Flow | -$1M | -$2M | -$2M | -$2M | -$879K |